<DOC>
	<DOCNO>NCT02539784</DOCNO>
	<brief_summary>Following call `` honey moon '' period , motor symptom Parkinson 's Disease ( PD ) become difficult control dopaminergic treatment alone . Deep brain stimulation ( DBS ) subthalamic nucleus internal globus pallidus help treat fluctuating parkinsonian patient restore decent quality life . However , DBS need long , complex invasive surgery succeed . Thus , critical need develop alternative treatment , accessible less invasive . Thoracic posterior spinal cord stimulation use decade treat chronic neuropathic pain . Safety efficacy already demonstrate neuropathic pain . Experimentally , SCS also demonstrate improve locomotor activity two different rodent ' model parkinson 's disease . The purpose study determine whether thoracic SCS safe could induce benefit motor parkinsonian symptom without impact cognitive function axial disability .</brief_summary>
	<brief_title>Thoracic Spinal Cord Stimulation Symptomatic Treatment Advanced Parkinson 's Disease</brief_title>
	<detailed_description>The present pilot study enroll 6 patient suffer advanced Parkinson Disease ( PD ) . Investigator assess safety , tolerance efficacy Spinal Cord Stimulation ( SCS ) frequencies 50 , 100 130 Hz shuffle randomize patient . Briefly , frequency evaluate immediately 4 week follow SCS initiation UPDRS-III , pain scale , Hauser 's diary . The best frequency patient select maintain activated 12 additional week . At end 12 week , new assessment include UPDRS , visual pain scale , `` SAINT-ANTOINE '' Pain Questionary , PDQ-39 ( quality life ) , daily L-dopa equivalent dose , MDRS ( cognitive status ) , LARS ( apathy status ) MADRS ( depression status ) compare inclusion data patient . Primary endpoint include safety thoracic SCS collect number adverse event efficacy measure UPDRS-III OFF med/ON stim 30 week .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patient 45 69 year old Affiliated French social health care system Menopausal contraception woman Parkinson 's disease accord UK PDSBB 's criterion diagnosis ≥ 5 year OFF UPDRSIII ≥ 25 Acute doparesponse ≥ 50 % UPDRSIII LDopa challenge Fluctuations period ≥ 25 % time awaken dyskinesia ≥ 25 % 3≤ Hoehn &amp; Yahr ≤ 4 No change antiparkinsonian drug last month Informed consent sign study Patients major protected Pregnancy Deep brain stimulation neurosurgical treatment MDRS Score &lt; 130 depression scale MADRS ≥ 20 Respiratory insufficiency ( surgery belly decubitus ) Abnormalities brain MRI evoke secondary parkinsonian syndrome Spinal cord 's injury MRI posterior cordonal 's pathology sensitive evoke potential Neuropathy EMG Prior spinal surgery spinal pathology dorsal level Patients already include therapeutic study Patient cardiac pacemaker , defibrillator implant active pacemaker Patient require diathermy process Patient pathology require MRI followup care</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stimulation</keyword>
</DOC>